InnoMed cuts ties with DeVilbiss

Wednesday, August 14, 2013

COCONUT CREEK, Fla. – InnoMed Technologies will no longer distribute its respiratory products exclusively through DeVilbiss Healthcare, the company announced Aug. 12.

“With competitive bidding and declining reimbursement rates, demands are being placed on manufacturers to reduce prices and in order to remain competitive with companies such as ResMed, Fisher & Paykel Healthcare and Philips Respironics, we believe moving toward a direct sales model is the right thing to do,” stated CEO Ron Richard in a press release. “DeVilbiss was a good partner for many years, but InnoMed has to plan for the future and create a solid business model for our customers and investors.”

The transition began Aug. 12.

By bringing its sales efforts in-house, InnoMed believes it will be able to broaden the reach of its product mix and renew its focus on customer care and educational support for patients and clinicians.

InnoMed’s flagship product line is the Nasal-Aire nasal interface, which debuted in 2001. It also manages and distributes the Hybrid oral nasal interface and the Aloha nasal pillow interface, among other products.

A sister company, Mergenet Medical, plans to launch a High Flow Therapy System in 2014.